🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anupam Verma

University of Maryland, Baltimore

ORCID: 0000-0001-6555-7924

Also affiliated with Primary Children's Hospital, Children's National, Sanjay Gandhi Post Graduate Institute of Medical Sciences, George Washington University, University of Utah, Virginia Cancer Specialists, John Snow (United States)

MedicineBusiness, Management and Accounting

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial”.

Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial

Blood Advances(2024)10.1182/bloodadvances.2024014415

N/A

0.224DataRank · unranked

3 citations

Maua Mosha, Cristina Tarango, Anupam Verma, Rukhmi Bhat, Nicole Kucine +8 more

Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial

Research and Practice in Thrombosis and Haemostasis(2024)10.1016/j.rpth.2024.102605

N/A

0.208DataRank · unranked

3 citations

Alexandra Miller, Maua Mosha, Christoph Male, Anupam Verma, Nicole Kucine +10 more

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial

Pediatric Blood & Cancer(2025)10.1002/pbc.31584

N/A

0.165DataRank · unranked

2 citations

Eric S. Schafer, Yueh‐Yun Chi, Jemily Malvar, Kenneth Heym, Andrew E. Place +22 more

Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease

Blood Advances(2025)10.1182/bloodadvances.2025017837

N/A

0.104DataRank · unranked

1 citations

Anupam Verma, Shelton A. Viola, Todd A. Alonzo, Yicheng Wang, Lisa Eidenschink Brodersen +15 more

A multicenter observational cohort study in survivors of Down Syndrome-associated acute leukemia (ALTE22C1): a report from the Children’s Oncology Group

BMC Cancer(2025)10.1186/s12885-025-14898-z

N/A

0DataRank · unranked

0 citations

Lauren Sanclemente, Lacey Hall, Olga A. Taylor, Michelle M. Nuño, Ravi Bhatia +16 more

Vaccination practices of pediatric oncologists from eight states

BMC Health Services Research(2023)10.1186/s12913-023-10160-z

N/A

0DataRank · unranked

5 citations

Heydon K. Kaddas, Echo L. Warner, Douglas Fair, Mark Fluchel, Elizabeth D Knackstedt +8 more

CRLF2 -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009499

N/A

0DataRank · unranked

8 citations

Samantha Scanlon, Hao‐Wei Wang, Constance M. Yuan, Alyssa Doverte, Jake Wellek +17 more

Management of Down Syndrome–Associated Leukemias

JAMA Oncology(2023)10.1001/jamaoncol.2023.2163

N/A

0DataRank · unranked

25 citations

Philip J. Lupo, Nirali N. Shah, Johann Hitzler, Karen R. Rabin, Anupam Verma